Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $83.07 ($249,215)
  2. 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $80.03 ($160,051)
  3. 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $74.92 ($153,586)
  4. 4/A Derivatives Options or other derivatives
  5. 4/A Derivatives Options or other derivatives
  6. 4/A Derivatives Options or other derivatives
  7. 4/A Derivatives Options or other derivatives
  8. 4/A Derivatives Options or other derivatives
  9. 4/A Derivatives Options or other derivatives
  10. 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $80.11 ($240,333)
  11. 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $84.58 ($173,389)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $86.76 ($173,512)
  16. 4 Open-market sale Principal Accounting Officer sold 272 shares at $84.94 ($23,104)
  17. 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $83.50 ($250,503)
  18. 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $97.58 ($200,039)
  19. 4 Open-market sale Director sold 9,000 shares at an average $93.55 ($841,926)
  20. 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $92.89 ($185,786)

Page 20 of 38 · 758 filings